Milestone Pharmaceuticals Inc.
MIST
$1.32
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 48.74% | -17.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.41% | -0.48% | |||
| Operating Income | -28.41% | 0.48% | |||
| Income Before Tax | -30.98% | -0.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.98% | -0.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.98% | -0.81% | |||
| EBIT | -28.41% | 0.48% | |||
| EBITDA | -28.47% | 0.47% | |||
| EPS Basic | -30.79% | -0.78% | |||
| Normalized Basic EPS | -30.86% | -0.79% | |||
| EPS Diluted | -30.79% | -0.78% | |||
| Normalized Diluted EPS | -30.86% | -0.79% | |||
| Average Basic Shares Outstanding | 0.13% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||